Article
Tideglusib enhances odontogenic differentiation in human dental pulp stem cellsin vitro
2 Dec 2022
Abstract excerpt
AIM: Tideglusib is a small molecule agonist of the canonical Wnt pathway. The present study investigated the influence of Tideglusib on human dental pulp stem cell (hDPSC) proliferation, apoptosis, migration and odonto/osteogenic differentiation. METHODOLOGY: hDPSCs were treated with 50, 100 nM or 200 nM Tideglusib. β-catenin accumulation was detected by immunofluorescence staining. Colony-forming unit ability...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
